Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_assertion description "[Agents targeting the JAK-STAT pathway have dominated the investigational therapeutic portfolio over the last five years resulting in the first and only approved agent for the treatment of patients with myelofibrosis (MF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_assertion evidence source_evidence_literature NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_assertion SIO_000772 25189730 NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_assertion wasDerivedFrom befree-2016 NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_assertion wasGeneratedBy ECO_0000203 NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1217016.RAx2dXrX-ealIRcGbXlxaz8tCPIECDa-d9FzZ7jdGGqTQ130_provenance.